Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03 2024 - 8:30AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, today announced that Paul
Bolno, MD, MBA, President and Chief Executive Officer, is scheduled
to present at the 42nd Annual J.P. Morgan Healthcare Conference in
San Francisco, CA on Wednesday, January 10, 2024, at 3:00 p.m. PT /
6:00 p.m. ET.
A live webcast of this presentation will be
available on the Investor Relations page of the Wave Life Sciences
website at http://ir.wavelifesciences.com. Replay of this
presentation will be archived and available on the site for a
limited time following the event.
About Wave Life SciencesWave
Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on X
(formerly Twitter) @WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2024 to May 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From May 2023 to May 2024